Fresenius Medical Care AG FMS
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 253.99M | 137.51M | 380.75M | 321.27M | 255.67M |
| Total Depreciation and Amortization | 415.40M | 414.07M | 346.13M | 418.79M | 410.88M |
| Total Amortization of Deferred Charges | -- | -- | 73.61M | -- | -- |
| Total Other Non-Cash Items | -14.42M | 132.79M | 187.57M | 23.44M | -106.95M |
| Change in Net Operating Assets | 345.62M | -418.91M | 177.99M | 103.46M | 319.89M |
| Cash from Operations | 1.00B | 265.46M | 1.17B | 866.97M | 879.49M |
| Capital Expenditure | -279.60M | -222.38M | -492.43M | -224.72M | -175.21M |
| Sale of Property, Plant, and Equipment | 5.86M | 3.60M | 5.88M | 348.40K | 8.94M |
| Cash Acquisitions | -2.23M | -5.46M | 3.93M | -3.71M | -10.52M |
| Divestitures | -809.50K | 1.79M | 44.88M | 167.85M | 1.25M |
| Other Investing Activities | -38.14M | 24.15M | -49.12M | -2.91M | 14.33M |
| Cash from Investing | -314.92M | -198.29M | -486.86M | -63.14M | -161.22M |
| Total Debt Issued | 447.25M | 172.93M | 497.87M | 72.68M | 1.10B |
| Total Debt Repaid | -594.28M | -189.23M | -212.17M | -676.96M | -555.08M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -144.64M | -347.33M | -434.17M | -151.12M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -465.42M | -- | 0.00 | 0.00 | -479.52M |
| Other Financing Activities | -77.70M | -72.45M | -59.93M | -379.85M | -45.44M |
| Cash from Financing | -895.03M | -510.23M | -242.58M | -1.33B | 89.91M |
| Foreign Exchange rate Adjustments | 2.45M | 21.89M | -37.46M | -18.96M | -80.18M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -206.90M | -421.17M | 399.16M | -542.37M | 728.00M |